GB0717336D0 - Novel compound - Google Patents

Novel compound

Info

Publication number
GB0717336D0
GB0717336D0 GB0717336A GB0717336A GB0717336D0 GB 0717336 D0 GB0717336 D0 GB 0717336D0 GB 0717336 A GB0717336 A GB 0717336A GB 0717336 A GB0717336 A GB 0717336A GB 0717336 D0 GB0717336 D0 GB 0717336D0
Authority
GB
United Kingdom
Prior art keywords
novel compound
novel
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0717336A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0717336A priority Critical patent/GB0717336D0/en
Publication of GB0717336D0 publication Critical patent/GB0717336D0/en
Priority to TW097133837A priority patent/TW200918527A/en
Priority to PE2008001550A priority patent/PE20091199A1/en
Priority to BRPI0816304 priority patent/BRPI0816304A2/en
Priority to CN200880115043A priority patent/CN101848903A/en
Priority to US12/203,946 priority patent/US20090170869A1/en
Priority to UY31324A priority patent/UY31324A1/en
Priority to ARP080103850A priority patent/AR068370A1/en
Priority to CL2008002622A priority patent/CL2008002622A1/en
Priority to PCT/EP2008/061664 priority patent/WO2009030716A1/en
Priority to AU2008294708A priority patent/AU2008294708B2/en
Priority to KR1020107007395A priority patent/KR20100059944A/en
Priority to ES08803634T priority patent/ES2384414T3/en
Priority to CA2697941A priority patent/CA2697941A1/en
Priority to AT08803634T priority patent/ATE554081T1/en
Priority to EP08803634A priority patent/EP2195307B1/en
Priority to US12/676,158 priority patent/US8288389B2/en
Priority to EA201070338A priority patent/EA201070338A1/en
Priority to MX2010002606A priority patent/MX2010002606A/en
Priority to JP2010523502A priority patent/JP5379796B2/en
Ceased legal-status Critical Current

Links

GB0717336A 2007-09-06 2007-09-06 Novel compound Ceased GB0717336D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB0717336A GB0717336D0 (en) 2007-09-06 2007-09-06 Novel compound
JP2010523502A JP5379796B2 (en) 2007-09-06 2008-09-04 Piperazine derivatives having affinity for histamine H3 receptor
CL2008002622A CL2008002622A1 (en) 2007-09-06 2008-09-04 1- (1-methylethyl) -4 - {[4- (tetrahydro-2h-pyran-4-yloxy) phenyl] carbonyl} piperazine and its hydrochloride salt; crystalline forms of salt; Preparation process; pharmaceutical composition; and use for the treatment or prophylaxis of cognitive impairment, fatigue or sleep disorder.
AU2008294708A AU2008294708B2 (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine H3 receptor
BRPI0816304 BRPI0816304A2 (en) 2007-09-06 2008-09-04 PIPERAZINE DERIVATIVE WITH AFFINITY FOR HISTAMINE H3 RECEIVER
CN200880115043A CN101848903A (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine H3 receptor
US12/203,946 US20090170869A1 (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine h3 receptor
UY31324A UY31324A1 (en) 2007-09-06 2008-09-04 PIPERAZINE DERIVATIVE THAT HAS AFFINITY FOR H3 HISTAMINE RECEIVER
ARP080103850A AR068370A1 (en) 2007-09-06 2008-09-04 1- (1-METHYTILE) -4 - {[4- (TETRAHIDRO-2H-PIRAN-4-ILOXI) PHENYL] CARBONIL} PIPERAZINE AND ITS HYDROCLORIDE SALT, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, ITS USE IN THE TREATMENT OR PROPHYLAXIS OF NEUROLOGICAL DISEASES AND PROCESS FOR PREPARATION.
TW097133837A TW200918527A (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine H3 receptor
PCT/EP2008/061664 WO2009030716A1 (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine h3 receptor
PE2008001550A PE20091199A1 (en) 2007-09-06 2008-09-04 PIPERAZINE DERIVATIVE HAVING AFFINITY FOR THE HISTAMINE H3 RECEPTOR
KR1020107007395A KR20100059944A (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine h3 receptor
ES08803634T ES2384414T3 (en) 2007-09-06 2008-09-04 Piperazine derivative that has an affinity for the histamine H3 receptor
CA2697941A CA2697941A1 (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine h3 receptor
AT08803634T ATE554081T1 (en) 2007-09-06 2008-09-04 PIPERAZINE DERIVATIVES WITH AFFINITY FOR HISTAMINE H3 RECEPTOR
EP08803634A EP2195307B1 (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine h3 receptor
US12/676,158 US8288389B2 (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine H3 receptor
EA201070338A EA201070338A1 (en) 2007-09-06 2008-09-04 DERIVATIVES OF PIPERAZINE, possessing affinity with respect to histamine H3 receptor
MX2010002606A MX2010002606A (en) 2007-09-06 2008-09-04 Piperazine derivative having affinity for the histamine h3 receptor.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0717336A GB0717336D0 (en) 2007-09-06 2007-09-06 Novel compound

Publications (1)

Publication Number Publication Date
GB0717336D0 true GB0717336D0 (en) 2007-10-17

Family

ID=38640340

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0717336A Ceased GB0717336D0 (en) 2007-09-06 2007-09-06 Novel compound

Country Status (1)

Country Link
GB (1) GB0717336D0 (en)

Similar Documents

Publication Publication Date Title
ZA201002605B (en) Oxadiazolidinedione compound
EP2152081A4 (en) Novel compounds
GB0706072D0 (en) Compound
EP2146745A4 (en) Novel compounds
GB0700076D0 (en) Compound
GB0720220D0 (en) Compound
IL200152A0 (en) Aza-bridged-ring compound
GB0725103D0 (en) Novel compounds
GB0705803D0 (en) Novel compounds
EP2128124A4 (en) Novel hexatriene- -carbonyl compound
GB0722779D0 (en) Compound
GB0706772D0 (en) Novel compound
GB0703973D0 (en) Novel compounds
GB0717336D0 (en) Novel compound
GB0717335D0 (en) Novel compound
GB0717333D0 (en) Novel compound
GB0717468D0 (en) Novel compound
GB0720917D0 (en) Novel compound
GB0717334D0 (en) Novel compound
GB0717338D0 (en) Novel compound
GB0717332D0 (en) Novel compound
GB0710864D0 (en) Novel compound
GB0714603D0 (en) Compound
GB0724770D0 (en) Compound
GB0719038D0 (en) Compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)